Title : Cangrelor inhibits the binding of the active metabolites of clopidogrel and prasugrel to P2Y12 receptors in vitro.

Pub. Date : 2016

PMID : 26270719






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 As cangrelor is administered intravenously, it is necessary to switch to an oral P2Y12 antagonist following PCI, such as the thienopyridines clopidogrel, and prasugrel or the non-pyridine ticagrelor. pyridine purinergic receptor P2Y12 Homo sapiens